ADIPOQ and cancer: According to the antitumor effects observed in response to Acrp30 [25, 26] and the opposite relation between its circulating levels and risk of developing cancer [27], initial reports have also investigated the possible anticancer role of AdipoRon in preclinical models, especially in pancreatic and ovarian cancer [28–30].